Literature DB >> 1346403

Immunological changes in cats with concurrent Toxoplasma gondii and feline immunodeficiency virus infections.

D S Lin1, D D Bowman, R H Jacobson.   

Abstract

To examine the immunological changes in cats concurrently infected with feline immunodeficiency virus (FIV) and Toxoplasma gondii, kittens (four per group) were inoculated with FIV, T. gondii, both agents, or no pathogens. Blood mononuclear cells and plasma were collected weekly for lymphocyte assays and serology. At week 14, spleen and lymph node cells were used for lymphocyte assays; brains and mesenteric lymph nodes were used for isolation of T. gondii. More T. gondii organisms were present in tissues of the dually infected cats than in tissues of cats with toxoplasmosis alone. Two dually infected cats and one cat infected with T. gondii developed chorioretinitis. Spleen, lymph node, and blood mononuclear cells from dually infected cats had the greatest reduction in mitogenic responses. By week 3, cats infected with FIV underwent a decrease in the number of CD4 cells that was not changed by concurrent T. gondii infection; the number of CD8 cells increased only in cats infected with T. gondii alone. For cats infected with T. gondii, the responses of lymphocytes to T. gondii antigen were not affected by FIV infection; the responses to FIV antigen were negligible in all groups. Overall, this study indicates that FIV infection favors T. gondii proliferation. Also, the establishment of toxoplasmosis may enhance FIV-induced immunodeficiency and is likely to cause a more rapid disease progression than that from infection with FIV alone.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1346403      PMCID: PMC264990          DOI: 10.1128/jcm.30.1.17-24.1992

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  35 in total

1.  A feline thymocyte antigen defined by a monoclonal antibody (FT2) identifies a subpopulation of non-helper cells capable of specific cytotoxicity.

Authors:  F W Klotz; M D Cooper
Journal:  J Immunol       Date:  1986-04-01       Impact factor: 5.422

2.  Impaired specific cellular response to HTLV-III before other immune defects in patients with HTLV-III infection.

Authors:  B Wahren; L Morfeldt-Månsson; G Biberfeld; L Moberg; P Ljungman; S Nordlund; U Bredberg-Rådén; A Werner; J Löwer; R Kurth
Journal:  N Engl J Med       Date:  1986-08-07       Impact factor: 91.245

3.  Toxoplasmic retinochoroiditis as an initial manifestation of the acquired immune deficiency syndrome.

Authors:  A Weiss; C E Margo; D K Ledford; R F Lockey; J H Brinser
Journal:  Am J Ophthalmol       Date:  1986-02-15       Impact factor: 5.258

4.  Enhancement of HIV-1 cytocidal effects in CD4+ lymphocytes by the AIDS-associated mycoplasma.

Authors:  S C Lo; S Tsai; J R Benish; J W Shih; D J Wear; D M Wong
Journal:  Science       Date:  1991-03-01       Impact factor: 47.728

5.  Kaposi's sarcoma in homosexual men. A seroepidemiologic case-control study.

Authors:  M Marmor; A E Friedman-Kien; S Zolla-Pazner; R E Stahl; P Rubinstein; L Laubenstein; D C William; R J Klein; I Spigland
Journal:  Ann Intern Med       Date:  1984-06       Impact factor: 25.391

Review 6.  Toxoplasmosis and the acquired immune deficiency syndrome.

Authors:  R E Holliman
Journal:  J Infect       Date:  1988-03       Impact factor: 6.072

7.  Serologic and immunologic studies in patients with AIDS in North America and Africa. The potential role of infectious agents as cofactors in human immunodeficiency virus infection.

Authors:  T C Quinn; P Piot; J B McCormick; F M Feinsod; H Taelman; B Kapita; W Stevens; A S Fauci
Journal:  JAMA       Date:  1987-05-15       Impact factor: 56.272

8.  Lymphocyte mitogen reactivity and enumeration of circulating B- and T-cells during feline leukemia virus infection in the cat.

Authors:  G L Cockerell; E A Hoover; S Krakowka; R G Olsen; D S Yohn
Journal:  J Natl Cancer Inst       Date:  1976-11       Impact factor: 13.506

9.  Evaluation of a computer-assisted, kinetics-based enzyme-linked immunosorbent assay for detection of coronavirus antibodies in cats.

Authors:  J E Barlough; R H Jacobson; D R Downing; K L Marcella; T J Lynch; F W Scott
Journal:  J Clin Microbiol       Date:  1983-02       Impact factor: 5.948

10.  Immunological crossreactivity between the human immunodeficiency virus type 1 virion infectivity factor and a 170-kD surface antigen of Schistosoma mansoni.

Authors:  J Khalife; J M Grzych; R Pierce; J C Ameisen; A M Schacht; H Gras-Masse; A Tartar; J P Lecocq; A Capron
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307

View more
  6 in total

1.  Caring for pets of immunocompromised persons.

Authors:  F J Angulo; C A Glaser; D D Juranek; M R Lappin; R L Regnery
Journal:  Can Vet J       Date:  1995-04       Impact factor: 1.008

Review 2.  Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen.

Authors:  M Bendinelli; M Pistello; S Lombardi; A Poli; C Garzelli; D Matteucci; L Ceccherini-Nelli; G Malvaldi; F Tozzini
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

3.  Feline immunodeficiency virus predisposes cats to acute generalized toxoplasmosis.

Authors:  M G Davidson; J B Rottman; R V English; M R Lappin; M B Tompkins
Journal:  Am J Pathol       Date:  1993-11       Impact factor: 4.307

Review 4.  Feline immunodeficiency virus infection: an overview.

Authors:  K Hartmann
Journal:  Vet J       Date:  1998-03       Impact factor: 2.688

Review 5.  Feline immune system.

Authors:  D S Lin
Journal:  Comp Immunol Microbiol Infect Dis       Date:  1992-01       Impact factor: 2.268

6.  Pathogen exposure in endangered island fox (Urocyon littoralis) populations: Implications for conservation management.

Authors:  Deana L Clifford; Jonna A K Mazet; Edward J Dubovi; David K Garcelon; Timothy J Coonan; Patricia A Conrad; Linda Munson
Journal:  Biol Conserv       Date:  2006-06-10       Impact factor: 5.990

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.